Back to search

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

Data up to Jan 2025

Published2002
Citations377
References23

Total Citations Per Year

Abstract

References (23)

Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions

1999 • 3,605 citations

Classification of chronic viral hepatitis: a need for reassessment

1991 • 1,526 citations

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

2001 • 1,065 citations

Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor

1999 • 947 citations

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

2002 • 894 citations

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1999 • 685 citations

Etiopathogenesis of Nonalcoholic Steatohepatitis

2001 • 678 citations

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

1997 • 649 citations

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

1997 • 628 citations

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3

2000 • 590 citations

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral‐related steatosis

2002 • 571 citations

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

2002 • 467 citations

Hepatitis C Virus NS5A Colocalizes with the Core Protein on Lipid Droplets and Interacts with Apolipoproteins

2002 • 300 citations

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C

2001 • 294 citations

Genotype‐specific mechanisms for hepatic steatosis in chronic hepatitis C infection

2002 • 171 citations

Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates

1995 • 121 citations

Steatosis and intrahepatic hepatitis C virus in chronic hepatitis

1999 • 112 citations

Expression of liver steatosis in hepatitis C virus infection and pattern of response to α-interferon

2001 • 77 citations

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

1998 • 60 citations

Noninvasive assessment of hepatic triglyceride content in humans with13C nuclear magnetic resonance spectroscopy

1996 • 36 citations

Molecular epidemiology of hepatitis C in Australia

1998 • 35 citations

Efficacy and tolerance of a 6‐month treatment course of daily interferon‐α2a for chronic hepatitis C with cirrhosis

1997 • 27 citations

Noninvasive assessment of hepatic triglyceride content in humans with 13C nuclear magnetic resonance spectroscopy

1996 • 12 citations

Cited By (0)

Loading...
Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis… (2002) – Hepatology | Metascience Observatory Explorer